Related Experiment Video

Updated: Jun 17, 2026

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

[Botulinum toxin A in children with infantile cerebral palsy: indications and treatment concepts]

R Placzek1

  • 1Sektion Kinderorthopädie, Centrum für Muskuloskeletale Chirurgie, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland. richard.placzek@charite.de

Der Orthopade
|December 25, 2009
PubMed

Insights

Botulinum toxin A (BoNT-A) is a safe and effective treatment for children with cerebral palsy. The new "Key-Muscle Concept" provides a standardized, effective, and safe approach to optimize motor development throughout childhood.

Area of Science:

  • Neurology
  • Pediatrics
  • Rehabilitation Medicine

Context:

  • Botulinum toxin A (BoNT-A) is a recognized therapy for pediatric cerebral palsy.
  • Current treatment lacks a standardized injection strategy.
  • Long-term therapy is crucial for motor development and preventing contractures.

Purpose:

  • To address the lack of a standardized injection strategy for BoNT-A in children with cerebral palsy.
  • To propose a modern treatment concept that balances safety, efficacy, and accessibility.
  • To support individual motor development milestones.

Summary:

  • The
  • Key-Muscle Concept
  • offers a standardized approach to BoNT-A treatment in pediatric cerebral palsy.
  • This concept utilizes moderate dose recommendations.
  • It aims to optimize motor development and prevent fixed contractures.

Impact:

  • Provides a standardized and effective treatment protocol for BoNT-A therapy in pediatric cerebral palsy.
  • Enhances the management of motor development in children with cerebral palsy.
  • Ensures the availability and efficacy of BoNT-A treatment throughout a child's growth period.

More Related Videos

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy08:24

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy

Published on: August 11, 2023

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...